Condition
Pre-motor Parkinson Disease
Total Trials
2
Recruiting
0
Active
2
Completed
0
Key Insights
Highlights
Treatment Research
1 treatments under study, led by Carvedilol
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Phase 2 (2)
Trial Status
Active Not Recruiting2
Clinical Trials (2)
Research Network
Common Treatments
- Carvedilol2
Active Sponsors
- Michele Tagliati, MD1
- Cedars-Sinai Medical Center1
Top Investigators
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Related Conditions
- Rem Sleep Behavior Disorder2
- Symptomatic Parkinson Disease2